Carson Wealth (CWM LLC)’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44K | Buy |
5,441
+3,810
| +234% | +$30.8K | ﹤0.01% | 3381 |
|
|
2025
Q1 | $13K | Buy |
1,631
+1,161
| +247% | +$9.25K | ﹤0.01% | 3963 |
|
|
2024
Q4 | $7K | Buy |
470
+7
| +2% | +$104 | ﹤0.01% | 4072 |
|
|
2024
Q3 | $7K | Buy |
463
+84
| +22% | +$1.27K | ﹤0.01% | 3961 |
|
|
2024
Q2 | $6K | Buy |
379
+24
| +7% | +$380 | ﹤0.01% | 3798 |
|
|
2024
Q1 | $7K | Buy |
355
+169
| +91% | +$3.33K | ﹤0.01% | 3531 |
|
|
2023
Q4 | $4K | Sell |
186
-39
| -17% | -$839 | ﹤0.01% | 3620 |
|
|
2023
Q3 | $4K | Sell |
225
-100
| -31% | -$1.78K | ﹤0.01% | 3586 |
|
|
2023
Q2 | $7K | Buy |
325
+292
| +885% | +$6.29K | ﹤0.01% | 3294 |
|
|
2023
Q1 | $1K | Sell |
33
-540
| -94% | -$16.4K | ﹤0.01% | 3893 |
|
|
2022
Q4 | $12K | Buy |
573
+180
| +46% | +$3.77K | ﹤0.01% | 2707 |
|
|
2022
Q3 | $10K | Buy |
393
+320
| +438% | +$8.14K | ﹤0.01% | 2692 |
|
|
2022
Q2 | $2K | Buy |
+73
| New | +$2K | ﹤0.01% | 3381 |
|
|
2022
Q1 | – | Sell |
-10
| Closed | – | – | 3791 |
|
|
2021
Q4 | $0 | Buy |
+10
| New | – | ﹤0.01% | 3598 |
|